Online citations, reference lists, and bibliographies.
← Back to Search

A Retrospective Review Of The Frequency Of Infections And Patterns Of Antibiotic Utilization On A Palliative Care Unit.

J. Pereira, S. Watanabe, G. Wolch
Published 1998 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Various disease-related and therapy-induced factors make cancer patients susceptible to infections. The epidemiology and management of infections in neutropenic cancer patients and patients with primary hematological malignancies has been widely reported, but very few studies have characterized infections and their management in palliative care patients. We conducted a retrospective review of 100 consecutive admissions to an acute palliative care unit with the objective of assessing overall and site-specific frequencies of infections, the pathogens involved and their antibiotics sensitivities, and the pattern of antibiotic utilization. The mean age was 64 +/- 11.5 years, the mean length of stay was 29.8 +/- 28.2 days, and 70% of patients died on the unit. Only one case of neutropenia was identified. Fifty-five of the 100 patients were diagnosed with a total of 74 separate infections. The most frequent sites of infections were the urinary tract (39.2%), the respiratory tract (36.5%), skin and subcutaneous tissues (12.2%), and blood (5.4%). Fifty-four culture-positive infections were identified. Overall, the most common organisms were Escherichia coli (22.9%), Staphylococcus aureus (20%), and Enterococcus (11.4%). Fifty-three of the 74 (71.6%) infections were treated with antibiotics. The decision-making process regarding treatment versus nontreatment of an infection can be complex in terminally ill patients and needs to be individualized. Symptom control is the primary objective in the majority of cases. The appropriate management of infections, with specific attention to measures that would improve patients' quality of life, should be a research priority in patients with advanced cancer.
This paper references
10.1001/JAMA.1992.03480160087040
Decisions Near the End of Life.
R. J. Mcmurray (2015)
10.1007/BF00326634
Gram-negative bacteremia
S. Schimpff (2004)
10.1097/00000542-194105000-00013
The Pharmacological Basis of Therapeutics
L. Goodman (1941)
10.1016/0885-3924(94)90187-2
The use of hypodermoclysis for rehydration in terminally ill cancer patients.
R. Fainsinger (1994)
10.1016/0885-3924(94)90117-1
The use of corticosteroids in the management of bilateral malignant ureteric obstruction.
R. Chye (1994)
10.1016/S0196-6553(89)80013-6
CDC definitions for nosocomial infections.
B. Yangco (1989)
10.1111/j.1532-5415.1991.tb02871.x
Prevalence and Characteristics of Nursing Home‐Acquired Infections in the Aged
J. Magaziner (1991)
Nosocomial urinary tract infections
S. TschudiMadsen (1972)
10.1017/S0195941700060355
Brief report: nosocomial infection rates in a cancer treatment center.
G. Robinson (1984)
10.1002/MPO.2950180309
Nosocomial septicemia in the cancer patient: the influence of central venous access devices, neutropenia, and type of malignancy.
V. Morrison (1990)
10.1097/00008390-199508000-00014
Handbook of Supportive Care in Cancer
J. Klastersky (1995)
10.1016/S0305-7372(75)80005-3
Infections in cancer patients.
G. Bodey (1975)
10.1016/0885-3924(94)90200-3
Corticosteroids as adjuvant analgesics.
S. Watanabe (1994)
10.1016/0014-2964(72)90036-9
Causes of death in patients with cancer.
J. Klastersky (1972)
10.1002/1097-0142(197402)33:2<568::AID-CNCR2820330236>3.0.CO;2-2
Causes of death in cancer patients
J. Inagaki (1974)
10.7326/0003-4819-87-1-133_2
Common symptoms of disease in the elderly
H. Hodkinson (1976)
10.1177/082585979401000407
Management of Nosocomial Respiratory Tract Infections in Terminally Ill Cancer Patients
K. Green (1994)
10.1093/CLINIDS/11.6.954
Risk of infectious complications in patients taking glucocorticosteroids.
A. Stuck (1989)
10.1016/S0025-7125(16)30052-9
Parenteral versus oral antibiotic therapy.
W. Craig (1995)
10.1016/0196-6553(88)90053-3
CDC definitions for nosocomial infections, 1988.
J. Garner (1988)
10.1002/1097-0142(19820701)50:1<187::AID-CNCR2820500134>3.0.CO;2-Y
Rates of hospital‐acquired bloodstream infections in patients with specific malignancy
J. Mayo (1982)
10.1016/S0889-8588(18)30221-1
Evolving risk factors for infectious complications of cancer therapy.
S. Chanock (1993)
10.1086/645727
Nosocomial infection rates at an oncology center.
C. Rotstein (1988)
10.1016/S0025-7125(16)30057-8
Empiric therapy for infections in the febrile, neutropenic, compromised host.
H. Giamarellou (1995)
10.1016/0885-3924(92)90085-V
The use of urinary catheters in terminally ill cancer patients.
R. Fainsinger (1992)
10.3109/9780203909799-2
Therapy of infections in cancer patients
J. Klastersky (1999)
Intractable pain in patients with advanced head and neck tumors: a possible role of local infection.
E. Bruera (1986)
10.1016/0885-3924(94)90141-4
Symptom control in terminally ill patients with malignant bowel obstruction (MBO).
R. Fainsinger (1994)
10.1001/archinte.1984.00350150042013
Current Clinical Topics in Infectious Diseases
J. Remington (1980)
10.1016/0195-6701(93)90092-E
Incidence of hospital-acquired infection.
G. Ayliffe (1993)
10.1002/(SICI)1097-0142(19970215)79:4<835::AID-CNCR21>3.0.CO;2-#
The frequency and clinical course of cognitive impairment in patients with terminal cancer
J. Pereira (1997)
10.1146/ANNUREV.NU.06.070186.001023
Nutrition and infection.
G. Keusch (1986)
10.1111/j.1532-5415.1994.tb06072.x
A Retrospective Review of Nosocomial Infections in an Acute Rehabilitative and Chronic Population at a Large Skilled Nursing Facility
M. Smith (1994)
10.1111/j.1532-5415.1989.tb05686.x
Utility of Fever, White Blood Cells, and Differential Count in Predicting Bacterial Infections in the Elderly
M. Wasserman (1989)
10.1016/S0025-7125(16)30055-4
Considerations in antimicrobial prescribing.
M. Y. Ma (1995)
10.1017/S0195941700055533
Nosocomial urinary tract infection: a prospective evaluation of 108 catheterized patients.
A. Hartstein (1981)
10.1001/archinte.1995.00430110089009
Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths.
D. Pittet (1995)
10.7326/0003-4819-114-9-818_5
Principles and Practice of Infectious Diseases
G. Mandell (1979)
10.1016/0885-3924(90)90014-B
Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer.
E. Bruera (1989)
10.1016/0885-3924(95)00065-7
Occult infection as a cause of hip pain in a patient with metastatic breast cancer.
J. Mackey (1995)
10.1016/0195-6701(86)90107-6
National prevalence survey of hospital-acquired infections in Italy, 1983.
M. Moro (1986)
10.1016/0885-3924(95)00161-1
Chronic nausea in advanced cancer patients: a retrospective assessment of a metoclopramide-based antiemetic regimen.
E. Bruera (1996)
10.1016/0002-9343(77)90876-2
Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases.
C. Singer (1977)
10.7326/0003-4819-106-1-65
The complete blood count and leukocyte differential count. An approach to their rational application.
M. Shapiro (1987)



This paper is referenced by
10.1089/jpm.2012.0634
Is it appropriate to withdraw antibiotics in terminal patients with cancer with infection?
An-Hsuan Chih (2013)
10.1177/0269216315583031
Acute symptomatic complications among patients with advanced cancer admitted to acute palliative care units: A prospective observational study
D. Hui (2015)
10.15761/GDT.1000121
Feasibility of subcutaneous antibiotics for palliative care patients
R. Gallardo (2017)
10.1017/CBO9780511527081.057
Infections in patients with advanced cancer
R. Navari (2003)
10.1016/J.JPAINSYMMAN.2004.08.009
"Beauty is only skin deep": prevalence of dermatologic disease on a palliative care unit.
C. Barnabe (2005)
10.1016/j.jpainsymman.2012.09.010
A nationwide analysis of antibiotic use in hospice care in the final week of life.
J. Albrecht (2013)
10.1016/B978-0-323-05674-8.50100-6
Antimicrobial Use in the Dying
Thomas G. Fraser (2009)
10.1007/s005200000143
Infectious complications of advanced cancer
J. Homsi (2014)
10.1016/B978-0-323-05674-8.50095-5
Infections In Palliative Medicine
Ruth L. Lagman (2009)
10.1038/sj.bjc.6600659
Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation
V. C. Pratt (2002)
10.1016/S0885-3924(03)00040-X
Antimicrobial use in patients with advanced cancer receiving hospice care.
P. H. White (2003)
10.1007/s00520-018-4090-8
Antimicrobial therapy in palliative care: an overview
F. Macedo (2018)
10.1016/S0213-005X(02)72824-3
Evolución del uso de antibióticos en un centro sociosanitario de ámbito hospitalario en Cataluña
M. Vaqueiro (2002)
10.1300/J103v18n02_01
PIE On-Line
J. Epstein (2000)
Management of Infections in Palliative and Terminal Cancer Care
Léčba infekcí (2013)
10.1080/13685538.2019.1575353
Palliative care infections and antibiotic cost: a vicious circle
O. Dagli (2019)
10.1213/01.ANE.0000132545.19806.3B
Access denied; care impaired: the benefits of having online medical information available at the point-of-care.
B. Finegan (2004)
10.1080/09699260.2000.11746883
The Role of the Internet in Palliative Care
Arun Rajagopal (2000)
10.1177/1049909114540033
Wishes of Patients With Terminal Cancer and Influencing Factors Toward the Use of Antibiotics in Taiwan
C. Yao (2015)
10.1272/JNMS.80.481
A retrospective study of risk factors for infection in cancer patients receiving specialist palliative care.
Ryo Yajima (2013)
10.1016/S0031-3955(02)00034-2
Caring for children with advanced cancer integrating palliative care.
J. Wolfe (2002)
10.1007/s40266-014-0182-4
Decision Making About Change of Medication for Comorbid Disease at the End of Life: An Integrative Review
R. T. C. M. V. Nordennen (2014)
10.1097/SAP.0b013e3181cf9f4a
Online Resources for Melanoma
J. Taylor (2010)
10.1111/J.1467-8519.2005.00450.X
Anti-infective therapy at the end of life: ethical decision-making in hospice-eligible patients.
P. Ford (2005)
10.1007/s00520-002-0377-9
Antibiotic prescription for fever episodes in hospice patients
L. Chen (2002)
10.2512/JSPM.9.2_301
Retrospective analysis of antibiotics use to infections in one palliative care unit
Takatoyo Kambayashi (2014)
10.1179/cih.2010.3.1.24
Healthcare tourism: Accelerating diffusion through a more effective use of communication channels
Corinne M. Karuppan (2010)
10.1007/s00520-011-1084-1
Antibiotics in palliative medicine—results from a prospective epidemiological investigation from the HOPE survey
S. Stiel (2011)
10.1097/00024665-200305000-00010
Online Cancer Support Groups: A Review of the Research Literature
P. Klemm (2003)
10.1089/jpm.2017.0147
An Examination of Factors Affecting the Length of Stay in a Palliative Care Center.
M. Dincer (2018)
10.1177/1049909111432625
Antimicrobial Use at the End of Life Among Hospitalized Patients With Advanced Cancer
A. Thompson (2012)
10.1136/jme.28.2.109
Factors affecting physicians' decisions to forgo life-sustaining treatments in terminal care
H. Hinkka (2002)
See more
Semantic Scholar Logo Some data provided by SemanticScholar